SCHEMBL15319

SCHEMBL15319

O=C(O)N1CCNCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17100538 1.00 CA2 (0.56)
SCHEMBL6961568 1.00
Hydrochloric Acid SCHEMBL1408979 0.97 CA2 (0.54)
Ammonia Solution, Strong SCHEMBL4674734 0.97 CA2 (0.54)
SCHEMBL5031106 0.97 CA2 (0.54)
Water SCHEMBL11193463 0.97 CA2 (0.54)
Hydrochloric Acid SCHEMBL125486 0.97 CA2 (0.54)
Hydrochloric Acid SCHEMBL18116041 0.97 CA2 (0.54)
Water SCHEMBL10607939 0.97 CA2 (0.54)
SCHEMBL31040426 0.97 CA2 (0.54)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 7303 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3723754-B1 IMIDAZO [1,2-C] QUINAZOLIN-5-AMINE COMPOUNDS WITH A2A ANTAGONIST PROPERTIES MERCK SHARP & DOHME LLC (US) 2026-05-13 EP claimed
EP-4100410-B1 MUSCARINIC RECEPTOR 4 ANTAGONISTS AND METHODS OF USE NEUROCRINE BIOSCIENCES INC (US) 2026-04-22 EP claimed
EP-4263518-B1 NEW QUINAZOLINONE DERIVATIVES HOFFMANN LA ROCHE (CH) 2026-04-01 EP claimed
US-12583821-B2 Salt of omecamtiv mecarbil and process for preparing salt CYTOKINETICS, INC. (US) 2026-03-24 US claimed
US-12577597-B2 Transgenic microorganisms and synthesis of piperazic acid, piperazic acid containing products, and derivatives thereof WASHINGTON UNIVERSITY (US) 2026-03-17 US claimed
EP-4649136-A1 GENETIC MODIFICATION OF MICROBES FOR PRODUCTION OF NITROGEN AND CARBON-CONTAINING COMPOUNDS Fertis India Pvt Ltd (IN) 2025-11-19 EP claimed
EP-4251624-B1 TRICYCLIC CARBOXAMIDE DERIVATIVES AS PRMT5 INHIBITORS AMGEN INC (US) 2025-10-29 EP claimed
EP-4301736-B1 MACROCYCLIC COMPOUNDS AS PROTEASOME SUBUNIT BETA TYPE-5 INHIBITORS LEAD DISCOVERY CENTER GMBH (DE) 2025-10-08 EP claimed
WO-2025094035-A1 TOLL-LIKE RECEPTOR AGONISTS AND CONJUGATES THEREOF PFIZER INC. (US) 2025-05-08 WO claimed
EP-3423452-B1 WNT SIGNALING PATHWAY INHIBITORS FOR TREATMENTS OF DISEASE UNIV MARYLAND (US) 2025-05-07 EP claimed
US-5167941-A Sulfur dioxide; cationic polyelectrolyte stabilizers THE DOW CHEMICAL COMPANY (US) 1992-12-01 US claimed
US-5098681-A Piperaznes having carbonyl groups THE DOW CHEMICAL COMPANY (US) 1992-03-24 US claimed
EP-0471592-A2 Process for absorption of sulfur compounds from fluids using certain piperidines, piperazines, or anhydrides of monocarboxylic amino acids THE DOW CHEMICAL COMPANY (US) 1992-02-19 EP claimed
EP-0126454-B1 FLAMEPROOF POLYMERIC COMPOSITIONS Montedison S.p.A. (IT) 1987-11-19 EP claimed
EP-0229667-A2 Peptidylaminodiols ABBOTT LABORATORIES (US) 1987-07-22 EP claimed
EP-0080992-B1 1-PIPERAZINOCARBOXYLATES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AB Ferrosan (SE) 1987-07-15 EP claimed
US-4599375-A SELF-EXTINGUISHING MONTEDISON S.P.A. (IT) 1986-07-08 US claimed
EP-0126454-A2 Flameproof polymeric compositions Montedison S.p.A. (IT) 1984-11-28 EP claimed
EP-0080992-A2 1-Piperazinocarboxylates, process for their preparation and pharmaceutical compositions containing them AB Ferrosan (SE) 1983-06-08 EP claimed
US-4247549-A Piperazine-1-carboxylic acid esters possessing antidepressant or analgesic activity ICI AMERICAS INC. (US) 1981-01-27 US claimed